Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WIRES Pharma is a health-tech and drug discovery platform company focused on AI- and quantum-enabled pharmaceutical R&D. The company positions itself as a collaborative venture between Qulectron and the Wires Group and markets the Wires Pharma Simulator as its flagship product for faster, lower-cost compound discovery and research collaboration. Its offering appears to be software and workflow infrastructure rather than a disclosed therapeutic pipeline, with capabilities such as simulation, secure collaboration, and regulatory support tools. Based on currently available public information, WIRES Pharma serves pharmaceutical companies, biotech startups, and academic researchers rather than commercializing named drug candidates of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WIRES.